Article info
PDFCardiac risk factors and prevention
Original research
Effectiveness of polypill for primary and secondary prevention of cardiovascular disease: a pragmatic cluster-randomised controlled trial (PolyPars)
- Correspondence to Dr Sadaf G Sepanlou, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran 14117-13135, Iran (the Islamic Republic of); sepanlou{at}yahoo.com
Citation
Effectiveness of polypill for primary and secondary prevention of cardiovascular disease: a pragmatic cluster-randomised controlled trial (PolyPars)
Publication history
- Received October 21, 2023
- Accepted February 14, 2024
- First published March 14, 2024.
Online issue publication
June 25, 2024
Article Versions
- Previous version (14 March 2024).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.